Monoamine Oxidase Inhibitors

"Monoamine Oxidase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)

Descriptor ID	D008996
MeSH Number(s)	D27.505.519.389.616
Concept/Terms	Monoamine Oxidase Inhibitors Monoamine Oxidase Inhibitors Inhibitors, Monoamine Oxidase Monoamine Oxidase Inhibitor Inhibitor, Monoamine Oxidase MAO Inhibitors Inhibitors, MAO RIMA (Reversible Inhibitor of Monoamine Oxidase A) RIMA (Reversible Inhibitor of Monoamine Oxidase A) Reversible Inhibitors of Monoamine Oxidase Reversible Inhibitors of Monoamine Oxidase Reversible Inhibitor of Monoamine Oxidase

Below are MeSH descriptors whose meaning is more general than "Monoamine Oxidase Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Enzyme Inhibitors [D27.505.519.389]
Monoamine Oxidase Inhibitors [D27.505.519.389.616]

Below are MeSH descriptors whose meaning is related to "Monoamine Oxidase Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Monoamine Oxidase Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Monoamine Oxidase Inhibitors" by people in this website by year, and whether "Monoamine Oxidase Inhibitors" was a major or minor topic of these publications.

Bar chart showing 16 publications over 12 distinct years, with a maximum of 2 publications in 1998 and 2006 and 2020 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	0	1	1
1998	0	2	2
2006	1	1	2
2008	0	1	1
2012	1	0	1
2013	0	1	1
2017	1	0	1
2019	0	1	1
2020	2	0	2
2021	2	0	2
2024	1	0	1

Below are the most recent publications written about "Monoamine Oxidase Inhibitors" by people in Profiles.

Aghimien MO, Kolawole Q, Igbinoba PO, Musa MA, Latinwo L. Non-cytotoxic 3-Acetylcoumarin as an Attractive Target for Human Monoamine Oxidase (HMAO) Enzymes. Anticancer Res. 2024 Jun; 44(6):2335-2341.

View in: PubMed
Patel P, Pol A, Kalaria D, Date AA, Kalia Y, Patravale V. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson's therapy. Eur J Pharm Biopharm. 2021 Aug; 165:66-74.

View in: PubMed
Tarpley M, Oladapo HO, Strepay D, Caligan TB, Chdid L, Shehata H, Roques JR, Thomas R, Laudeman CP, Onyenwoke RU, Darr DB, Williams KP. Identification of harmine and ?-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. Eur J Pharm Sci. 2021 Jul 01; 162:105821.

View in: PubMed
Musa MA, Badisa VLD, Aghimien MO, Eyunni SVK, Latinwo LM. Identification of 7,8-dihydroxy-3-phenylcoumarin as a reversible monoamine oxidase enzyme inhibitor. J Biochem Mol Toxicol. 2021 Feb; 35(2):e22651.

View in: PubMed
Zarmouh NO, Messeha SS, Mateeva N, Gangapuram M, Flowers K, Eyunni SVK, Zhang W, Redda KK, Soliman KFA. The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells. Molecules. 2020 May 11; 25(9).

View in: PubMed
Ojo OA, Afon AA, Ojo AB, Ajiboye BO, Okesola MA, Aruleba RT, Adekiya TA, Oyinloye BE. Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer's diseases. J Food Biochem. 2019 03; 43(3):e12772.

View in: PubMed
Zarmouh NO, Eyunni SK, Soliman KF. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor. BMC Complement Altern Med. 2017 Jan 10; 17(1):34.

View in: PubMed
Kowalko JE, Rohner N, Rompani SB, Peterson BK, Linden TA, Yoshizawa M, Kay EH, Weber J, Hoekstra HE, Jeffery WR, Borowsky R, Tabin CJ. Loss of schooling behavior in cavefish through sight-dependent and sight-independent mechanisms. Curr Biol. 2013 Oct 07; 23(19):1874-83.

View in: PubMed
Mazzio E, Deiab S, Park K, Soliman KF. High throughput screening to identify natural human monoamine oxidase B inhibitors. Phytother Res. 2013 Jun; 27(6):818-28.

View in: PubMed
Mellman T, Lydiard RB. Posttraumatic stress disorder: characteristics and treatment. J Clin Psychiatry. 2008 Jan; 69(1):e2.

View in: PubMed

People

Explore

Similar Concepts

Top Journals